100205
论文已发表
提 交 论 文
注册即可获取Ebpay生命的最新动态
注 册
IF 收录期刊
- 3.3 Breast Cancer (Dove Med Press)
- 3.4 Clin Epidemiol
- 2.5 Cancer Manag Res
- 2.9 Infect Drug Resist
- 3.5 Clin Interv Aging
- 4.7 Drug Des Dev Ther
- 2.7 Int J Chronic Obstr
- 6.6 Int J Nanomed
- 2.5 Int J Women's Health
- 2.5 Neuropsych Dis Treat
- 2.7 OncoTargets Ther
- 2.0 Patient Prefer Adher
- 2.3 Ther Clin Risk Manag
- 2.5 J Pain Res
- 2.8 Diabet Metab Synd Ob
- 2.8 Psychol Res Behav Ma
- 3.0 Nat Sci Sleep
- 1.8 Pharmgenomics Pers Med
- 2.7 Risk Manag Healthc Policy
- 4.2 J Inflamm Res
- 2.1 Int J Gen Med
- 4.2 J Hepatocell Carcinoma
- 3.7 J Asthma Allergy
- 1.9 Clin Cosmet Investig Dermatol
- 2.7 J Multidiscip Healthc
公司动态
2018 Ebpay生命 3 本期刊喜获影响因子
我们非常高兴的宣布，随着最新一年的影响因子发布，Ebpay生命旗下又有 3 本期刊喜获影响因子，他们分别是 Nature and Science of Sleep（2018 年影响因子：3.054），Pharmacogenomics and Personalized Medicine（2018 年影响因子：2.721），Risk Management and Healthcare Policy（2018 年影响因子：2.283）。至此，Ebpay生命期刊旗下共有17本期刊进入 SCI 期刊行列。
以下是这些期刊的名录：
- Cancer Management and Research 2.243
- Clinical Epidemiology 3.178
- Clinical Interventions in Aging 2.585 (5 year impact 3.195)
- Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 3.319
- Drug Design, Development and Therapy 3.208 (5 year impact 3.254)
- Infection and Drug Resistance 3.000
- International Journal of Chronic Obstructive Pulmonary Disease 3.274 (5 year impact 3.553)
- International Journal of Nanomedicine 4.471 (5 year impact 5.029)
- Journal of Pain Research 2.236 (5 year impact 2.558)
- Nature and Science of Sleep 3.054 *New*
- Neuropsychiatric Disease and Treatment 2.228 (5 year impact 2.673)
- OncoTargets and Therapy 3.046 (5 year impact 2.968)
- Patient Preference and Adherence 2.097 (5 year impact 2.234)
- Pharmacogenomics and Personalized Medicine 2.721 *New*
- Psychology Research and Behavior Management 1.840
- Risk Management and Healthcare Policy 2.283 *New*
- Therapeutics and Clinical Risk Management 1.824 (5 year impact 2.050)
